Evidence map›Paper›PMID 33103072›Full record

ArticleiScience2020

Metabolome Changes during

Neema Jamshidi, Xiuling Xu, Katharina von Löhneysen, Katrin Soldau, Rob P Mohney, Edward D Karoly, Mike Scott, Jeffrey S Friedman

Open access · goldAbstract read
In one paragraph

Article in iScience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Red Blood Cell Omics and Machine Learning in Transfusion Medicine: Singularity Is Near.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Neema JamshidiUniversity of California, San Diego, Institute of Engineering in Medicine, La Jolla, CA, USA.
Xiuling XuThe Scripps Research Institute, Department of Molecular and Experimental Medicine, La Jolla, CA, USA.
Katharina von LöhneysenMitokinin, Inc, San Francisco, CA, USA.
Katrin SoldauUniversity of California, San Diego, Department of Pathology, La Jolla, CA, USA.
Rob P MohneyMetabolon, Inc, Durham, NC, USA.
Edward D KarolyMetabolon, Inc, Durham, NC, USA.
Mike ScottSan Diego Mesa College, Chemistry Department, San Diego, CA, USA.
Jeffrey S FriedmanFriedman Bioventure, Inc, San Diego, CA, USA.
Metabolon (United States) · USMitokinin (United States) · USSan Diego Mesa College · USScripps Research Institute · USUniversity of California, Los Angeles · USUniversity of California San Diego · US

Funding

The Effect of Nanoparticle Encapsulated Resveratrol on Treatment of PeriodontitisKL2TR001882 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Elizabeta Nemeth · 2016 to 2026
$13.1M
Hemolytic Anemia: Biochemical, Molecular and Proteomic DiagnosticsR01DK080232 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDMAN, JEFFREY S · 2009 to 2010
$950k
Oxidized Proteome of Normal/Sideroblastic Erythroid CellR21DK075763 · NIDDK · SCRIPPS RESEARCH INSTITUTE, THE · PI FRIEDMAN, JEFFREY S · 2008 to 2009
$517k
NCATS NIH HHS KL2 TR001882NIDDK NIH HHS R01 DK080232NIDDK NIH HHS R21 DK075763
6 · The paper itself

Abstract

Understanding the mechanisms for cellular aging is a fundamental question in biology. Normal red blood cells (RBCs) survive for approximately 100 days, and their survival is likely limited by functional decline secondary to cumulative damage to cell constituents, which may be reflected in altered metabolic capabilities. To investigate metabolic changes during

Indexed as

Medical BiochemistryMetabolomics

Identifiers

PMID33103072
PMCPMC7575880
OpenAlexW3089803450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.